Skip to main content

Table 1 Correlation between ERα/Src and ERα/PI3K interactions

From: Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant

Variable

ERα/PI3K ≤9, no. (%)

ERα/PI3K >9, no. (%)

P

ERα/Src

Low (≤ 10)

181 (69.6)

68 (44.2)

<0.001

High (> 10)

79 (30.4)

86 (55.8)